Variant report

Variant	nsv892070
Chromosome Location	chr9:2610307-2633921
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr9:2616716-2617355	GM12878	blood:	n/a	n/a
2	ATF3	chr9:2623434-2623749	H1-hESC	embryonic stem cell:	n/a	chr9:2623474-2623494
3	BACH1	chr9:2621410-2621682	H1-hESC	embryonic stem cell:	n/a	n/a
4	BATF	chr9:2617416-2617678	GM12878	blood:	n/a	n/a
5	BATF	chr9:2617015-2617371	GM12878	blood:	n/a	n/a
6	BATF	chr9:2621265-2621528	GM12878	blood:	n/a	n/a
7	BATF	chr9:2617423-2617686	GM12878	blood:	n/a	n/a
8	BATF	chr9:2621293-2621482	GM12878	blood:	n/a	n/a
9	BATF	chr9:2617020-2617395	GM12878	blood:	n/a	n/a
10	BCL11A	chr9:2616785-2617375	GM12878	blood:	n/a	chr9:2617113-2617122
11	BCL11A	chr9:2616999-2617318	GM12878	blood:	n/a	chr9:2617113-2617122
12	BHLHE40	chr9:2623345-2623847	A549	lung:	n/a	chr9:2623484-2623493 chr9:2623485-2623494 chr9:2623485-2623494
13	BHLHE40	chr9:2622428-2622971	GM12878	blood:	n/a	chr9:2622781-2622797 chr9:2622746-2622762
14	BHLHE40	chr9:2621446-2621718	K562	blood:	n/a	chr9:2621658-2621674 chr9:2621583-2621599
15	BHLHE40	chr9:2621241-2621747	HepG2	liver:	n/a	chr9:2621658-2621674 chr9:2621583-2621599
16	BHLHE40	chr9:2623210-2623849	GM12878	blood:	n/a	chr9:2623484-2623493 chr9:2623485-2623494 chr9:2623485-2623494
17	BHLHE40	chr9:2623320-2623869	HepG2	liver:	n/a	chr9:2623484-2623493 chr9:2623485-2623494 chr9:2623485-2623494
18	BHLHE40	chr9:2621256-2621931	GM12878	blood:	n/a	chr9:2621658-2621674 chr9:2621798-2621814 chr9:2621583-2621599 chr9:2621799-2621815
19	BRCA1	chr9:2623380-2623503	HepG2	liver:	n/a	n/a
20	CCNT2	chr9:2621423-2621804	K562	blood:	n/a	n/a
21	CEBPB	chr9:2624317-2624652	K562	blood:	n/a	chr9:2624483-2624494 chr9:2624485-2624496 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624496 chr9:2624483-2624496 chr9:2624483-2624496 chr9:2624483-2624496
22	CEBPB	chr9:2611134-2611431	A549	lung:	n/a	chr9:2611265-2611276
23	CEBPB	chr9:2624344-2624623	Hela-S3	cervix:	n/a	chr9:2624483-2624494 chr9:2624485-2624496 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624496 chr9:2624483-2624496 chr9:2624483-2624496 chr9:2624483-2624496
24	CEBPB	chr9:2611088-2611458	IMR90	lung:	n/a	chr9:2611265-2611276
25	CEBPB	chr9:2621175-2621530	HepG2	liver:	n/a	n/a
26	CEBPB	chr9:2624354-2624556	H1-hESC	embryonic stem cell:	n/a	chr9:2624483-2624494 chr9:2624485-2624496 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624496 chr9:2624483-2624496 chr9:2624483-2624496 chr9:2624483-2624496
27	CEBPB	chr9:2621158-2621559	H1-hESC	embryonic stem cell:	n/a	n/a
28	CEBPB	chr9:2624376-2624611	MCF-7	breast:	n/a	chr9:2624483-2624494 chr9:2624485-2624496 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624496 chr9:2624483-2624496 chr9:2624483-2624496 chr9:2624483-2624496
29	CEBPB	chr9:2623740-2624029	IMR90	lung:	n/a	chr9:2623970-2623983
30	CEBPB	chr9:2621167-2621499	A549	lung:	n/a	n/a
31	CEBPB	chr9:2611122-2611379	H1-hESC	embryonic stem cell:	n/a	chr9:2611265-2611276
32	CEBPB	chr9:2624305-2624658	IMR90	lung:	n/a	chr9:2624483-2624494 chr9:2624485-2624496 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624496 chr9:2624483-2624496 chr9:2624483-2624496 chr9:2624483-2624496
33	CEBPB	chr9:2624289-2624719	A549	lung:	n/a	chr9:2624483-2624494 chr9:2624485-2624496 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624496 chr9:2624483-2624496 chr9:2624483-2624496 chr9:2624483-2624496
34	CEBPB	chr9:2611109-2611418	HepG2	liver:	n/a	chr9:2611265-2611276
35	CEBPB	chr9:2621194-2621559	MCF-7	breast:	n/a	n/a
36	CEBPB	chr9:2621171-2621587	HepG2	liver:	n/a	n/a
37	CEBPB	chr9:2624309-2624662	HepG2	liver:	n/a	chr9:2624483-2624494 chr9:2624485-2624496 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624496 chr9:2624483-2624496 chr9:2624483-2624496 chr9:2624483-2624496
38	CEBPB	chr9:2623681-2624674	A549	lung:	n/a	chr9:2624483-2624494 chr9:2624485-2624496 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2623970-2623983 chr9:2624485-2624494 chr9:2624485-2624494 chr9:2624485-2624496 chr9:2624483-2624496 chr9:2624483-2624496 chr9:2624483-2624496
39	CEBPB	chr9:2621124-2621632	A549	lung:	n/a	n/a
40	CEBPB	chr9:2621303-2621449	HepG2	liver:	n/a	n/a
41	CEBPB	chr9:2621212-2621491	K562	blood:	n/a	n/a
42	CEBPB	chr9:2621155-2621549	IMR90	lung:	n/a	n/a
43	CEBPB	chr9:2623648-2624167	A549	lung:	n/a	chr9:2623970-2623983
44	CHD1	chr9:2620886-2622127	IMR90	lung:	n/a	n/a
45	CHD1	chr9:2622947-2623141	H1-hESC	embryonic stem cell:	n/a	n/a
46	CHD1	chr9:2621190-2621402	H1-hESC	embryonic stem cell:	n/a	n/a
47	CHD2	chr9:2623436-2623773	H1-hESC	embryonic stem cell:	n/a	n/a
48	CHD2	chr9:2621237-2621569	H1-hESC	embryonic stem cell:	n/a	n/a
49	CHD2	chr9:2623655-2623720	HepG2	liver:	n/a	n/a
50	CHD2	chr9:2621351-2621538	GM12878	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:2623684-2623734	MCF-7	breast:	n/a
2	chr9:2621094-2621144	ProgFib	skin:	n/a
3	chr9:2621379-2621429	AG09319	gingival:	n/a
4	chr9:2621918-2621968	HCF	heart:	n/a
5	chr9:2622584-2622634	HCF	heart:	n/a
6	chr9:2622584-2622634	Hela-S3	cervix:	n/a
7	chr9:2623562-2623612	HCPEpiC	choroid plexus:	n/a
8	chr9:2621379-2621429	T-47D	breast:	n/a
9	chr9:2623146-2623196	HRPEpiC	eye:	n/a
10	chr9:2621918-2621968	MCF10A-Er-Src	breast:	n/a
11	chr9:2622584-2622634	HRPEpiC	eye:	n/a
12	chr9:2621918-2621968	Jurkat	blood:	n/a
13	chr9:2619314-2619364	GM06990	blood:	n/a
14	chr9:2623146-2623196	CMK	blood:	n/a
15	chr9:2621094-2621144	GM06990	blood:	n/a
16	chr9:2623562-2623612	AG09309	skin:	n/a
17	chr9:2619314-2619364	NHBE	bronchial:	n/a
18	chr9:2621918-2621968	AG09319	gingival:	n/a
19	chr9:2622584-2622634	HCM	heart:	n/a
20	chr9:2623562-2623612	AG04450	lung:	fetal
21	chr9:2623684-2623734	GM12891	blood:	n/a
22	chr9:2623146-2623196	GM06990	blood:	n/a
23	chr9:2626347-2626397	BE2_C	brain:	n/a
24	chr9:2621918-2621968	AoSMC	blood vessel:	n/a
25	chr9:2622584-2622634	Hepatocyte	liver:	n/a
26	chr9:2621094-2621144	GM12891	blood:	n/a
27	chr9:2623146-2623196	MCF-7	breast:	n/a
28	chr9:2621094-2621144	GM12892	blood:	n/a
29	chr9:2621094-2621144	MCF-7	breast:	n/a
30	chr9:2619314-2619364	HCPEpiC	choroid plexus:	n/a
31	chr9:2621918-2621968	NT2-D1	testis:	n/a
32	chr9:2619314-2619364	GM12892	blood:	n/a
33	chr9:2621918-2621968	AG04450	lung:	fetal
34	chr9:2626347-2626397	SKMC	muscle:	n/a
35	chr9:2623146-2623196	SK-N-SH	brain:	n/a
36	chr9:2626347-2626397	Jurkat	blood:	n/a
37	chr9:2623562-2623612	MCF10A-Er-Src	breast:	n/a
38	chr9:2621918-2621968	H1-hESC	embryonic stem cell:	embryo
39	chr9:2619314-2619364	Hela-S3	cervix:	n/a
40	chr9:2623684-2623734	H1-hESC	embryonic stem cell:	embryo
41	chr9:2623146-2623196	AG04450	lung:	fetal
42	chr9:2621379-2621429	CMK	blood:	n/a
43	chr9:2626347-2626397	HNPCEpiC	eye:	n/a
44	chr9:2622584-2622634	AG04450	lung:	fetal
45	chr9:2623562-2623612	PFSK-1	brain:	n/a
46	chr9:2619314-2619364	Caco-2	colon:	n/a
47	chr9:2619314-2619364	AG10803	skin:	n/a
48	chr9:2623146-2623196	AoSMC	blood vessel:	n/a
49	chr9:2621379-2621429	Hela-S3	cervix:	n/a
50	chr9:2626347-2626397	T-47D	breast:	n/a

No.	Distal block	Cell Line	Cell type
1	chr9:2621566..2623636-chr9:2638581..2641950,3	MCF-7	breast:
2	chr9:2619846..2622881-chr9:2631771..2635491,3	MCF-7	breast:
3	chr9:2613986..2615496-chr9:2621852..2624711,2	MCF-7	breast:
4	chr9:2228114..2228719-chr9:2625246..2626097,2	MCF-7	breast:
5	chr9:2620203..2621987-chr9:2627062..2629533,2	MCF-7	breast:
6	chr9:2618162..2620045-chr9:2621820..2624612,2	K562	blood:
7	chr9:2611403..2613342-chr9:2621748..2624247,2	MCF-7	breast:
8	chr9:2624771..2627181-chr9:2629101..2631938,2	MCF-7	breast:
9	chr9:2621586..2624495-chr9:2626376..2628188,2	K562	blood:
10	chr9:2617041..2619621-chr9:2621235..2624621,3	MCF-7	breast:
11	chr9:2620987..2624573-chr9:2639977..2643677,3	MCF-7	breast:
12	chr9:2616577..2619117-chr9:2619974..2622873,2	MCF-7	breast:
13	chr9:2624771..2627181-chr9:2629101..2631938,2	MCF-7	breast:
14	chr9:2613768..2615804-chr9:2618805..2621446,2	K562	blood:
15	chr9:2622798..2625667-chr9:2640741..2642429,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KIAA0020-1	chr9:2611229-2611526	l_3727_chr9:2411588-2611526_ovary
2	lnc-KIAA0020-1	chr9:2621229-2621413	ENSG00000236404
3	lnc-KIAA0020-1	chr9:2622100-2622373	NR_015375
4	lnc-KIAA0020-1	chr9:2622100-2622373	ENSG00000236404
5	lnc-KIAA0020-1	chr9:2621229-2621413	ENSG00000236404.4
6	lnc-KIAA0020-1	chr9:2619998-2621792	NONHSAT130002

Variant related genes	Relation type
ENSG00000236404	TF binding region
VLDLR	TF binding region
ENSG00000236404	CpG island
VLDLR	CpG island
ENSG00000147852	chromatin interactions
ENSG00000236404	chromatin interactions
SPRED1	miRNA target sites

Extended variants
information (count: 1096 )
Associated
traits (count: 108 )

Variant overlapped rSNPs/rCNVs (count:1096 , 50 per page) page: 1 2 3 4 5 6 7 ... 22

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1003047	chr9:2610307-2610308	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs193045800	chr9:2610309-2610310	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs552144700	chr9:2610323-2610324	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs377130049	chr9:2610360-2610361	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs185697971	chr9:2610382-2610383	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs546860770	chr9:2610399-2610400	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs566789540	chr9:2610418-2610419	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs189008834	chr9:2610489-2610490	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs554246349	chr9:2610526-2610527	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs567746486	chr9:2610527-2610528	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs538103695	chr9:2610543-2610544	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs62535726	chr9:2610571-2610572	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs574464231	chr9:2610590-2610591	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs141565552	chr9:2610625-2610626	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs181045946	chr9:2610638-2610639	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs545587534	chr9:2610656-2610657	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs373536095	chr9:2610658-2610659	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs2889264	chr9:2610706-2610707	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs76322239	chr9:2610715-2610716	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs572739511	chr9:2610719-2610720	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs540609715	chr9:2610727-2610728	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs12343894	chr9:2610747-2610748	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs369010458	chr9:2610776-2610777	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs574118926	chr9:2610777-2610778	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs543081075	chr9:2610822-2610823	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs552716278	chr9:2610878-2610879	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs62535727	chr9:2610881-2610882	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs185624059	chr9:2610882-2610883	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs559375724	chr9:2610907-2610908	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs188816515	chr9:2610957-2610958	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs547790004	chr9:2611001-2611002	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs567636916	chr9:2611020-2611021	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs117558446	chr9:2611095-2611096	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs577139339	chr9:2611102-2611103	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs550257132	chr9:2611151-2611152	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs570180684	chr9:2611163-2611164	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs57967892	chr9:2611203-2611204	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs116293758	chr9:2611237-2611238	Enhancers Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
39	rs79182315	chr9:2611244-2611245	Enhancers Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
40	rs76392374	chr9:2611284-2611285	Enhancers Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
41	rs139710630	chr9:2611292-2611293	Enhancers Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
42	rs145080590	chr9:2611298-2611299	Enhancers Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
43	rs181330517	chr9:2611327-2611328	Enhancers Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
44	rs576908765	chr9:2611377-2611378	Enhancers Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
45	rs1378060	chr9:2611392-2611393	Enhancers Weak transcription Bivalent Enhancer	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs559526617	chr9:2611393-2611394	Enhancers Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
47	rs528317095	chr9:2611394-2611395	Enhancers Weak transcription Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
48	rs147590667	chr9:2611418-2611419	Enhancers Weak transcription	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
49	rs1378061	chr9:2611483-2611484	Enhancers Weak transcription	Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
50	rs530114574	chr9:2611488-2611489	Enhancers Weak transcription	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:108)

Disease	PMID	Source
Gastric cancer	16715143	CNVD
Glioblastoma multiforme	22286061	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Intracranial aneurysm	16715129	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Disorders of sex development	22290220	CNVD
Glioblastoma multiforme	21080181	CNVD
Sudden cardiac death	19188705	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21952639	CNVD
Disorders of sex development	21048976	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
abnormal development	18461090	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Autism	20531469	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Myelofibrosis	22110671	CNVD
Developmental delay	21373258	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Hepatocellular carcinoma	18803288	CNVD
Schizophrenia	23813976	CNVD
Ovarian cancer	22355333	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Schizophrenia	20967226	CNVD
Maculopathy	22355348	CNVD
Ovarian cancer	21781307	CNVD
T-cell lymphomas	22341440	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:963 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:2594000-2610400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
2	chr9:2597800-2613800	Weak transcription	Psoas Muscle	Psoas
3	chr9:2599000-2610600	Weak transcription	Ovary	ovary
4	chr9:2601000-2613600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
5	chr9:2603400-2613600	Weak transcription	Fetal Lung	lung
6	chr9:2608800-2612000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
7	chr9:2609000-2611400	Weak transcription	Fetal Heart	heart
8	chr9:2609600-2615200	Weak transcription	Brain Substantia Nigra	brain
9	chr9:2610200-2610600	Enhancers	Primary neutrophils fromperipheralblood	blood
10	chr9:2610200-2611600	Enhancers	HUES48 Cell Line	embryonic stem cell
11	chr9:2610200-2611600	Enhancers	HUES64 Cell Line	embryonic stem cell
12	chr9:2610200-2611800	Enhancers	ES-I3 Cell Line	embryonic stem cell
13	chr9:2610400-2614000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
14	chr9:2610600-2611000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
15	chr9:2610600-2611200	Enhancers	Ovary	ovary
16	chr9:2610600-2611400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
17	chr9:2610600-2615800	Enhancers	iPS-18 Cell Line	embryonic stem cell
18	chr9:2610800-2611200	Enhancers	Placenta	Placenta
19	chr9:2610800-2611400	Bivalent Enhancer	HSMMtube	muscle
20	chr9:2610800-2611600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
21	chr9:2611000-2611200	Enhancers	H1 Cell Line	embryonic stem cell
22	chr9:2611000-2611200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
23	chr9:2611000-2611200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
24	chr9:2611000-2611400	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
25	chr9:2611000-2611400	Enhancers	iPS-20b Cell Line	embryonic stem cell
26	chr9:2611000-2611600	Enhancers	iPS-15b Cell Line	embryonic stem cell
27	chr9:2611400-2611600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
28	chr9:2611400-2612000	Enhancers	Fetal Heart	heart
29	chr9:2611400-2612400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
30	chr9:2611400-2612600	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
31	chr9:2611600-2612600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
32	chr9:2611600-2612600	Weak transcription	HUES48 Cell Line	embryonic stem cell
33	chr9:2611600-2612600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
34	chr9:2611600-2612600	Enhancers	Fetal Brain Male	brain
35	chr9:2611600-2612800	Weak transcription	HUES64 Cell Line	embryonic stem cell
36	chr9:2611600-2613800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
37	chr9:2611800-2613400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
38	chr9:2612000-2613600	Weak transcription	Fetal Heart	heart
39	chr9:2612000-2616600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
40	chr9:2612400-2616000	Enhancers	iPS-20b Cell Line	embryonic stem cell
41	chr9:2612600-2612800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
42	chr9:2612600-2612800	Enhancers	HUES48 Cell Line	embryonic stem cell
43	chr9:2612600-2612800	Enhancers	iPS-15b Cell Line	embryonic stem cell
44	chr9:2612600-2613600	Weak transcription	Fetal Brain Male	brain
45	chr9:2612600-2614000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
46	chr9:2612800-2613200	Weak transcription	HUES48 Cell Line	embryonic stem cell
47	chr9:2612800-2613200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
48	chr9:2612800-2614600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
49	chr9:2612800-2616000	Enhancers	HUES64 Cell Line	embryonic stem cell
50	chr9:2613000-2614000	Weak transcription	Right Atrium	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links